Andrea Wang‐Gillam
- Oncology top 0.2%
- Pancreatic and Hepatic Oncology Research 121
- Cancer Immunotherapy and Biomarkers 32
- Colorectal Cancer Treatments and Studies 30
- Cancer Cells and Metastasis 16
- Immunology top 0.5%
- Immune cells in cancer 18
- Cancer Research top 1%
- Cancer Genomics and Diagnostics 41
- Biotechnology top 2%
- Cancer Research and Treatments 17
-
- Neuroendocrine Tumor Research Advances 21
- Co-authors
- David G. DeNardoDavid C. LinehanBrett L. KnolhoffYu ZhuMelissa A. MeyerTimothy M. NyweningS. Peter GoedegebuureBrian L. West
- Cited by
- OncologyImmunologyCancer Research
- Journals
- JAMA (1 paper)Journal of Biological Chemistry (2 papers)Journal of Clinical Investigation (1 paper)
- Partner nations
- United StatesUnited KingdomTaiwan
In The Last Decade
Andrea Wang‐Gillam
185 papers receiving 8.0k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Oncology 5.9k
- Immunology 2.9k
- Cancer Research 1.5k
- Pulmonary and Respiratory Medicine 1.3k
- Biotechnology 288
Countries citing papers authored by Andrea Wang‐Gillam
This map shows the geographic impact of Andrea Wang‐Gillam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Wang‐Gillam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Wang‐Gillam more than expected).
Fields of papers citing papers by Andrea Wang‐Gillam
This network shows the impact of papers produced by Andrea Wang‐Gillam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Wang‐Gillam. The network helps show where Andrea Wang‐Gillam may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrea Wang‐Gillam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 11 | |
| 3 | 2023 | 7 | |
| 4 | 2023 | 10 | |
| 5 | 2022 | 24 | |
| 6 | 2022 | 6 | |
| 7 | 2021 | 22 | |
| 8 | 2021 | 9 | |
| 9 | 2020 | 24 | |
| 10 | 2020 | 91 | |
| 11 | 2018 | 145 | |
| 12 | 2018 | 32 | |
| 13 | HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinomabreakdown → | 2017 | 365 |
| 14 | 2017 | 39 | |
| 15 | 2017 | 0 | |
| 16 | 2017 | 2 | |
| 17 | 2016 | 60 | |
| 18 | CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Modelsbreakdown → | 2014 | 974 |
| 19 | Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axisbreakdown → | 2013 | 479 |
| 20 | Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responsesbreakdown → | 2012 | 759 |
About Andrea Wang‐Gillam
Andrea Wang‐Gillam is a scholar working on Oncology, Cancer Research and Biotechnology, having authored 195 papers that have together received 8.1k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (121 papers), Cancer Genomics and Diagnostics (41 papers), Cancer Immunotherapy and Biomarkers (32 papers), Colorectal Cancer Treatments and Studies (30 papers), Neuroendocrine Tumor Research Advances (21 papers), Immune cells in cancer (18 papers), Cancer Research and Treatments (17 papers) and Cancer Cells and Metastasis (16 papers). The work is most often cited by research in Oncology (5.9k citations), Immunology (2.9k citations) and Cancer Research (1.5k citations). Andrea Wang‐Gillam has collaborated with scholars based in United States, United Kingdom and Taiwan. Frequent co-authors include David G. DeNardo, David C. Linehan, Brett L. Knolhoff, Yu Zhu, Melissa A. Meyer, Timothy M. Nywening, S. Peter Goedegebuure, Brian L. West, Jonathan B. Mitchem and Jingqin Luo. Their work appears in journals such as JAMA, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.